Panacea Life Sciences Holdings annual operating margin
2014
2015
2019
2020
2021
2022
2023
Panacea Life Sciences Holdings Operating Margin Growth & History (PLSH)
Panacea Life Sciences Holdings's operating margin was −232.55% for fiscal 2023.
View full Panacea Life Sciences Holdings company overviewPanacea Life Sciences Holdings annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −232.55% | +114.86 pp |
| 2022 | 2022-12-31 | −347.41% | −59.14 pp |
| 2021 | 2021-12-31 | −288.26% | −229.96 pp |
| 2020 | 2020-12-31 | −58.31% | +3029.16 pp |
| 2019 | 2019-12-31 | −3,087.46% | — |
| 2015 | 2015-12-31 | −182,761.50% | −133435.45 pp |
| 2014 | 2014-12-31 | −49,326.06% | — |
Panacea Life Sciences Holdings quarterly operating margin
Q2.14
Q3.14
Q4.15
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q1.25
Q2.25
Q3.25
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2025 | 2025-09-30 | −341.35% | — |
| Q2 2025 | 2025-06-30 | −333.30% | — |
| Q1 2025 | 2025-03-31 | −82.70% | +17.38 pp |
| Q1 2024 | 2024-03-31 | −100.09% | +90.32 pp |
| Q4 2023 | 2023-12-31 | −184.07% | +239.45 pp |
| Q3 2023 | 2023-09-30 | −406.52% | −27.34 pp |
| Q2 2023 | 2023-06-30 | −269.11% | −4.99 pp |
| Q1 2023 | 2023-03-31 | −190.41% | +162.88 pp |
| Q4 2022 | 2022-12-31 | −423.52% | −238.04 pp |
| Q3 2022 | 2022-09-30 | −379.18% | −165.24 pp |
| Q2 2022 | 2022-06-30 | −264.13% | +195.02 pp |
| Q1 2022 | 2022-03-31 | −353.29% | — |
| Q4 2021 | 2021-12-31 | −185.48% | −173.87 pp |
| Q3 2021 | 2021-09-30 | −213.94% | +35.26 pp |
| Q2 2021 | 2021-06-30 | −459.15% | −472.18 pp |
| Q4 2020 | 2020-12-31 | −11.61% | +2356.91 pp |
| Q3 2020 | 2020-09-30 | −249.20% | +3110.01 pp |
| Q2 2020 | 2020-06-30 | 13.03% | +2050.72 pp |
| Q1 2020 | 2020-03-31 | −315.02% | +15929.37 pp |
| Q4 2019 | 2019-12-31 | −2,368.53% | — |
| Q3 2019 | 2019-09-30 | −3,359.21% | — |
| Q2 2019 | 2019-06-30 | −2,037.70% | — |
| Q1 2019 | 2019-03-31 | −16,244.39% | — |
| Q4 2015 | 2015-12-31 | −56,528.17% | — |
| Q3 2014 | 2014-09-30 | −35,160.09% | — |
| Q2 2014 | 2014-06-30 | −8,029.11% | — |
Panacea Life Sciences Holdings operating margin trends
Between the periods ended 2014-12-31 and 2023-12-31, Panacea Life Sciences Holdings's operating margin increased from −49,326.06% to −232.55%, a change of +49093.51 percentage points. The latest reported quarter, Q3 2025, shows −341.35%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Panacea Life Sciences Holdings source filings ↗